PhD Gabriela Segal
PhD Gabriela Segal
Dirección de correo verificada de
Citado por
Citado por
Prolonged survival of dendritic cell–vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor …
MN López, C Pereda, G Segal, L Munoz, R Aguilera, FE González, ...
Journal of Clinical Oncology 27 (6), 945-952, 2009
Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity
E Cao, MJ Watt, CJ Nowell, T Quach, JS Simpson, V De Melo Ferreira, ...
Nature Metabolism 3 (9), 1175-1188, 2021
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses
C Durán-Aniotz, G Segal, L Salazar, C Pereda, C Falcón, F Tempio, ...
Cancer Immunology, Immunotherapy 62, 761-772, 2013
A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-β+ tolerogenic dendritic cells
MN López, B Pesce, M Kurte, C Pérez, G Segal, J Roa, JC Aguillón, ...
Immunobiology 216 (10), 1117-1126, 2011
Target density, not affinity or avidity of antigen recognition, determines adoptive T cell therapy outcomes in a mouse lymphoma model
G Segal, S Prato, D Zehn, JD Mintern, JA Villadangos
The Journal of Immunology 196 (9), 3935-3942, 2016
Cell surface carbohydrates of symbiotic dinoflagellates and their role in the establishment of cnidarian–dinoflagellate symbiosis
G Tortorelli, C Rautengarten, A Bacic, G Segal, B Ebert, SK Davy, ...
The ISME journal 16 (1), 190-199, 2022
A candidate transporter allowing symbiotic dinoflagellates to feed their coral hosts
K Maor-Landaw, M Eisenhut, G Tortorelli, A van de Meene, S Kurz, ...
ISME communications 3 (1), 7, 2023
Underlying mechanisms of effective adoptive T cell therapy against a B cell lymphoma
G Segal Wasserman
884 Th1 and Th17 Profiles Induction and Treg Profiles Repression Are Associated With Immunological Responses and Long-term Patient Survival on Melanoma Patients Treated With …
C Duran, G Segal, L Salazar, C Pereda, C Falcon, F Tempio, C Perez, ...
european journal of cancer, S214, 2012
Abstract B18: Induction of Th1/Th17 and inhibition of Th3 cellular profile by DC-based immunotherapy is associated with immunological and clinical anti-tumor responses in …
C Durán, G Segal, L Salazar, C Pereda, T Fabián, F Salazar-Onfray, ...
Clinical Cancer Research 16 (7_Supplement), B18-B18, 2010
Dendritic Cells Therapy Induces CD4+ T Memory Cells with Concomitant Profile TH1-TH17 in Responding Melanoma Patients
L Salazar, M López, C Durán, G Segal, F Salazar-Onfray
Clinical Immunology, S87, 2010
Regulatory T cells affect the DC-mediated immunotherapy outcome in melanoma patients
MN López, G Segal, C Pereda, R Aguilera, A Ginesta, D Reyes, ...
Clinical Immunology, S116, 2007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–12